Top Markets
Coin of the day
Kenvue Inc. Kenvue Inc.

Kenvue Inc.

KVUE
Pozycja w akcjach #632
Kenvue Inc. operates as a consumer health company worldwide. The company... Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Cena akcji
$17.52
Kapitalizacja rynkowa
$33.58B
Zmiana (1 dzień)
-0.28%
Zmiana (1 rok)
-26.08%
Kraj
US
Handel Kenvue Inc. (KVUE)
Zyski dla Kenvue Inc. (KVUE)
Zyski w Dec 2025 TTM: $2.00B
Według najnowszych raportów finansowych Kenvue Inc., obecny zysk firmy wynosi $2.00B. W roku 2023 firma osiągnęła zysk w wysokości $2.19B, spadek w porównaniu do zysku z roku 2022, który wynosił $2.64B. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Kenvue Inc. od 2019 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $2.00B 41.27%
2024 $1.42B -35.39%
2023 $2.19B -16.95%
2022 $2.64B -9.85%
2021 $2.93B -387.89%
2020 $-1.02B -147.92%
2019 $2.12B 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$20.64B 932.37%
US
$9.97B 398.69%
FR
$9.80B 390.08%
GB
$3.06B 53.03%
US
$1.46B -26.88%
IN